$IRDM
Iridium Communications Inc. Stock $irdm

$irdm Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023012131 Filed on April 20, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$193.1M	$205.3M	$168.2M
YoY Change	10.4%	22.03%	14.8%
Cost Of Revenue	$51.55M	$63.74M	$44.60M
YoY Change	10.16%	42.91%	23.21%
Gross Profit	$141.6M	$141.5M	$123.6M
YoY Change	10.49%	14.49%	12.07%
Gross Profit Margin	73.31%	68.95%	73.49%
Selling, General & Admin	$37.34M	$38.68M	$26.10M
YoY Change	30.27%	48.2%	15.21%
% of Gross Profit	26.38%	27.33%	21.12%
Research & Development	$5.626M	$3.878M	$2.619M
YoY Change	88.41%	48.07%	-3.61%
% of Gross Profit	3.97%	2.74%	2.12%
Depreciation & Amortization	$114.6M	$75.82M	$75.66M
YoY Change	51.38%	0.21%	-0.33%
% of Gross Profit	80.93%	53.57%	61.21%
Operating Expenses	$157.5M	$42.56M	$28.72M
YoY Change	397.77%	48.19%	13.19%
Operating Profit	-$15.97M	$23.15M	$19.23M
YoY Change	-176.79%	20.36%	113.32%
Interest Expense	-$18.72M	-$17.89M	-$14.58M
YoY Change	26.68%	22.73%	-36.07%
% of Operating Profit		-77.29%	-75.79%
Other Income/Expense, Net	$419.0K	-$17.67M	-$14.59M
YoY Change	-102.79%	21.16%	-36.02%
Pretax Income	-$34.28M	$5.500M	$4.600M
YoY Change	-690.95%	19.57%	-133.33%
Income Tax	-$5.211M	-$5.500M	$1.800M
% Of Pretax Income		-100.0%	39.13%
Net Earnings	-$30.74M	$9.775M	$2.824M
YoY Change	-774.59%	246.14%	-154.49%
Net Earnings / Revenue	-15.92%	4.76%	1.68%
Basic Earnings Per Share	-$0.24	$0.08	$0.02
Diluted Earnings Per Share	-$0.24	$0.08	$21.42K
COMMON SHARES
Basic Shares Outstanding	125.9M shares	126.0M shares	130.3M shares
Diluted Shares Outstanding	126.2M shares	128.7M shares	131.8M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.5M	$126.6M	$232.0M
YoY Change	-54.46%	-45.44%	4.36%
Cash & Equivalents	$88.05M	$126.6M	$232.0M
Short-Term Investments
Other Short-Term Assets	$17.32M	$14.16M	$11.11M
YoY Change	35.0%	27.45%	10.02%
Inventory	$55.76M	$37.34M	$28.24M
Prepaid Expenses
Receivables	$92.15M	$100.6M	$80.06M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$268.7M	$278.7M	$351.4M
YoY Change	-21.63%	-20.69%	9.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.291B	$2.384B	$2.596B
YoY Change	-9.84%	-8.17%	-8.96%
Goodwill	$0.00
YoY Change
Intangibles	$41.93M	$42.19M	$43.61M
YoY Change	-2.98%	-3.27%	-3.34%
Long-Term Investments	$70.36M	$72.02M
YoY Change
Other Assets	$108.5M	$95.15M	$86.43M
YoY Change	-27.46%	10.09%	80.12%
Total Long-Term Assets	$2.512B	$2.593B	$2.726B
YoY Change	-8.13%	-4.87%	-7.42%
TOTAL ASSETS
Total Short-Term Assets	$268.7M	$278.7M	$351.4M
Total Long-Term Assets	$2.512B	$2.593B	$2.726B
Total Assets	$2.780B	$2.872B	$3.077B
YoY Change	-9.63%	-6.68%	-5.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.85M	$23.67M	$15.10M
YoY Change	76.05%	56.79%	52.38%
Accrued Expenses	$48.98M	$43.40M	$35.18M
YoY Change	20.76%	23.39%	1.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$16.50M	$16.50M	$16.50M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$124.2M	$116.3M	$95.69M
YoY Change	17.22%	21.57%	8.34%
LONG-TERM LIABILITIES
Long-Term Debt	$1.465B	$1.468B	$1.579B
YoY Change	-7.04%	-7.03%	-0.97%
Other Long-Term Liabilities	$58.18M	$15.39M	$19.20M
YoY Change	218.3%	-19.87%	-20.85%
Total Long-Term Liabilities	$1.523B	$15.39M	$19.20M
YoY Change	8231.3%	-19.87%	-20.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$124.2M	$116.3M	$95.69M
Total Long-Term Liabilities	$1.523B	$15.39M	$19.20M
Total Liabilities	$1.780B	$1.786B	$1.885B
YoY Change	-6.09%	-5.27%	-0.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$170.5M	-$83.12M	$42.92M
YoY Change	-911.39%	-293.67%	-80.94%
Common Stock	$1.119B	$1.127B	$1.127B
YoY Change	-0.85%	0.01%	-2.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.000B	$1.086B	$1.192B
YoY Change
Total Liabilities & Shareholders Equity	$2.780B	$2.872B	$3.077B
YoY Change	-9.63%	-6.68%	-5.8%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$30.74M	$9.775M	$2.824M
YoY Change	-774.59%	246.14%	-154.49%
Depreciation, Depletion And Amortization	$114.6M	$75.82M	$75.66M
YoY Change	51.38%	0.21%	-0.33%
Cash From Operating Activities	$87.05M	$68.94M	$65.77M
YoY Change	-12.77%	4.82%	29.56%
INVESTING ACTIVITIES
Capital Expenditures	$22.38M	$22.91M	$13.57M
YoY Change	-228.26%	68.82%	44.08%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$10.00M
YoY Change	-100.0%
Cash From Investing Activities	-$22.38M	-$32.91M	-$13.57M
YoY Change	-66.82%	142.52%	44.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$134.2M
YoY Change			126.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-86.98M	-$77.96M	-$141.3M
YoY Change	120.53%	-44.84%	123.39%
NET CHANGE
Cash From Operating Activities	87.05M	$68.94M	$65.77M
Cash From Investing Activities	-22.38M	-$32.91M	-$13.57M
Cash From Financing Activities	-86.98M	-$77.96M	-$141.3M
Net Change In Cash	-22.31M	-$42.18M	-$88.90M
YoY Change	214.41%	-52.55%	297.88%
FREE CASH FLOW
Cash From Operating Activities	$87.05M	$68.94M	$65.77M
Capital Expenditures	$22.38M	$22.91M	$13.57M
Free Cash Flow	$64.67M	$46.04M	$52.20M
YoY Change	-44.85%	-11.81%	26.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5400000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001418819
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	City Area Code CityAreaCode	703
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22102
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	125924403	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125924000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125902000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125924000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125902000	shares
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5400000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	300000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	800000	usd
CY2022Q4	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	500000	shares
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	rate
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	rate
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33963
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Iridium Communications Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1344998
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1750 Tysons Boulevard
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	McLean
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22102
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	703-287-7400
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	IRDM
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	125924403	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	126592000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	168770000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	100636000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82273000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	37335000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39776000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14162000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15385000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	278725000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	306204000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2383570000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2433305000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	72018000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	49853000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	95150000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	122072000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42187000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42577000	usd
CY2023Q1	us-gaap	Assets Assets	2871650000	usd
CY2022Q4	us-gaap	Assets Assets	2954011000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	16500000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	16500000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	23674000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	21372000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	43402000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	67963000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	32745000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	35742000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	116321000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	141577000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1467601000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1470685000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	142704000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	151569000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	44049000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	45265000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15385000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16360000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1786060000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1825456000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	126000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	126000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1126586000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1124610000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-83120000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47744000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	41998000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	51563000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1085590000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1128555000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2871650000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2954011000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	205273000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168219000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3878000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2619000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38684000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26103000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75819000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75661000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	182125000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	148986000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	23148000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	19233000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-17890000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14577000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17671000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14585000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5477000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4648000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5453000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1824000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1155000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9775000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2824000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127058000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130298000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128738000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131842000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9775000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2824000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	91000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1275000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-9656000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	27992000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	210000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32091000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1128555000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1287947000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14446000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8939000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2744000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	523000	usd
CY2023Q1	irdm	Adjustments To Additional Paid In Capital Stock Withheld To Cover Employee Taxes AdjustmentsToAdditionalPaidInCapitalStockWithheldToCoverEmployeeTaxes	7029000	usd
CY2022Q1	irdm	Adjustments To Additional Paid In Capital Stock Withheld To Cover Employee Taxes AdjustmentsToAdditionalPaidInCapitalStockWithheldToCoverEmployeeTaxes	3558000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	53123000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	134166000	usd
CY2023Q1	us-gaap	Dividends Dividends	213000	usd
CY2022Q1	us-gaap	Dividends Dividends	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	91000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1275000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-9656000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	27992000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9775000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2824000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1085590000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1191776000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9775000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2824000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5937000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1160000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75819000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75661000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12766000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8240000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1045000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1153000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1273000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	172000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18359000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16540000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2630000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-891000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1211000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1047000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1236000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1170000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1903000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-8532000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-10629000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3992000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	644000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-974000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-942000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68942000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	65770000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22905000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13568000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	10000000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32905000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13568000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-4125000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-4125000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	53123000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	134166000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2744000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	523000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7029000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3558000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-16428000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-77961000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141326000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-254000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42178000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-88898000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168770000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	320913000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126592000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232015000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	18774000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	13558000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	903000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	482000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6403000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2518000	usd
CY2023Q1	irdm	Capitalized Amortization Of Deferred Financing Costs CapitalizedAmortizationOfDeferredFinancingCosts	66000	usd
CY2022Q1	irdm	Capitalized Amortization Of Deferred Financing Costs CapitalizedAmortizationOfDeferredFinancingCosts	29000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1680000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	699000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	37335000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39776000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18084000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17964000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	20380000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	23014000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1129000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1202000	usd
CY2023Q1	irdm	Launch Service Costs LaunchServiceCosts	40000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	126592000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	168770000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5400000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	16084000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	21445000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	21445000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	21445000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	21445000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	56017000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	157881000	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	16500000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-16400000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	17400000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1484100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1487200000	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1501400000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1494300000	usd
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	21336000	usd
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	15303000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1111000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1182000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1330000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	389000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	300000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	800000	usd
CY2023Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	7700000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.10
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M24D
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-9656000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	27992000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-2936000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	8455000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	6181382	shares
CY2023Q1	irdm	Share Base Compensation Award Reduction In Shares Available For Issuance By Shares Issued Pursuant To Any Appreciation Award ShareBaseCompensationAwardReductionInSharesAvailableForIssuanceBySharesIssuedPursuantToAnyAppreciationAward	1	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1
CY2023Q1	irdm	Share Base Compensation Award Reduction In Shares Available For Issuance By Shares Issued Pursuant To Any Stock Award That Is Not An Appreciation Award ShareBaseCompensationAwardReductionInSharesAvailableForIssuanceBySharesIssuedPursuantToAnyStockAwardThatIsNotAnAppreciationAward	1.8	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	41365000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1573000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1185000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.97
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	49094000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	10.25
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	368000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.46
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	19993000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	814000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1681000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.35
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	53698000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	56000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.10
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1666000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.45
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1624000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.35
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M2D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	50305000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.98
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M23D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	49318000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1624000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.35
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y1M2D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	50298000	usd
CY2023Q1	irdm	Total Authorized Preferred Stock Number TotalAuthorizedPreferredStockNumber	2000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1500000	shares
CY2023Q1	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	500000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.13
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	400000	usd
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	900000	shares
CY2022Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	3800000	shares
CY2023Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	53100000	usd
CY2022Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	134200000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	126500000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	14300000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9400000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2824000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127058000	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5500000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5500000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.996
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	rate
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4600000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1800000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.392
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	rate
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9775000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130298000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128738000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131842000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	3600000	usd
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd

Files In Submission

Name	View Source	Status
0001628280-23-012131-index-headers.html	Edgar Link	pending
0001628280-23-012131-index.html	Edgar Link	pending
0001628280-23-012131.txt	Edgar Link	pending
0001628280-23-012131-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
irdm-20230331.htm	Edgar Link	pending
irdm-20230331.xsd	Edgar Link	pending
irdm-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
irdm-20230331_def.xml	Edgar Link	unprocessable
irdm-20230331_lab.xml	Edgar Link	unprocessable
irdm-20230331_htm.xml	Edgar Link	completed
irdm10-q33123exx311.htm	Edgar Link	pending
irdm10-q33123exx312.htm	Edgar Link	pending
irdm10-q33123exx321.htm	Edgar Link	pending
irdm2023annualshareawardgr.htm	Edgar Link	pending
irdm2023bonusplanex-103.htm	Edgar Link	pending
irdm2023perfshareawardgran.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
irdm-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRDM
Iridium Communications Inc. Stock $irdm

2023 Q2 Form 10-Q Financial Statement

#000162828023012131 Filed on April 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRDM Iridium Communications Inc. Stock $irdm

2023 Q2 Form 10-Q Financial Statement

#000162828023012131 Filed on April 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRDM
Iridium Communications Inc. Stock $irdm